In patients with MASH exhibiting F3-F4 fibrosis, activated HSCs and myofibroblasts exhibited a marked upregulation of the pro-fibrotic molecule, Cell Communication Network Factor 2 (CCN2), which subsequently potentiated HSC activation and aggravated liver fibrosis (102). This evidence concerns the gene CCN2 and Hepatic fibrosis.